Precision Medicine for Localized Prostate Cancer: Time to Move Beyond NCCN Risk Stratification?

Affiliations

¹ Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California.
² Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. Electronic address: sprattda@med.umich.edu.

Editorial

Zachary S Zumsteg et al. Int J Radiat Oncol Biol Phys. 2019.

. 2019 Jan 1;103(1):92-94.

doi: 10.1016/j.ijrobp.2018.09.040. Epub 2018 Dec 12.

¹ Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California.
² Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. Electronic address: sprattda@med.umich.edu.

No abstract available

Comment on

Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone Therapy.
Berlin A, Murgic J, Hosni A, Pintilie M, Salcedo A, Fraser M, Kamel-Reid S, Zhang J, Wang Q, Ch'ng C, Deheshi S, Davicioni E, van der Kwast T, Boutros PC, Bristow RG, Chua MLK. Berlin A, et al. Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):84-91. doi: 10.1016/j.ijrobp.2018.08.030. Epub 2018 Aug 29. Int J Radiat Oncol Biol Phys. 2019. PMID: 30170099